Running title: IR-induced NO regulates tumor hypoxia and radioresistance.
INTRODUCTION
Low oxygen conditions drastically decrease cellular radiosensitivity and facilitate the adaptive survival responses of tumors [1] . Hence, tumor hypoxia in most solid tumors is a well-known obstacle for successful radiotherapy. It occurs mainly as a result of the excess proliferation of tumor cells and the accompanying deficiency in blood and nutrient supplies [1] . Recently, various strategies to overcome the low radiosensitivity in tumor hypoxia have been developed, such as hypoxic sensitizers, hyperbaric oxygen, and angiogenesis inhibitors [2] .
A recent report demonstrated that treatment with nitric oxide (NO) donor (e.g. isosorbide dinitrate) increases both the partial pressure of oxygen (pO 2 ) in tissue and tumor radiosensitivity [3] . Thus, NO-mediated modulation of tumor blood flow could be a promising approach for improving cancer radiotherapy [4] . Meanwhile, several reports showed that ionizing radiation (IR) increases NO production and improves intratumoral circulation [5, 6] .
However, the NO synthase isoforms responsible for NO production in tumors exposed to IR remain uncertain. Sonveaux et al. demonstrated that IR increases endothelial nitric oxide synthase (eNOS) expression in tumor, leading to vasodilatation [5] . On the other hand, Li et al. reported that IR upregulates the expression level of inducible nitric oxide synthase (iNOS) and leads to the subsequent increase of angiogenesis in tumors [6] .
Fractionated irradiation is one of the conventional therapeutic regimens in the clinical setting and is known to utilize the reoxygenation effect. In 1972, Kallman proposed that IR reoxygenates hypoxic regions in tumors and decreases radioresistance [7] . However, the involvement of IR-induced NO in the reoxygenation of hypoxic regions has not been elucidated.
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It is extremely important to clarify the duration in which IR-induced NO has an influence on tumor reoxygenation, which is considered to be associated with radiosensitivity in tumors treated with fractionated irradiation.
We conducted this study to elucidate the mechanism by which IR stimulates NO production in tumors and the effect of IR-induced NO on tumor radiosensitivity. For this purpose, we employed immunohistochemistry and in vivo electron spin resonance (ESR) spectroscopy to trace the spatiotemporal changes of the tumor oxygenation status in murine SCCVII tumors exposed to IR. In addition, we evaluated nitric oxide synthase (NOS) expression and activity in tumors after IR to determine the source of IR-induced NO production.
MATERIALS AND METHODS

Tumor model and irradiation
Female C3H mice aged 6 weeks were purchased from Japan SLC (Hamamatsu, Japan). SCCVII cells, a squamous carcinoma cell line derived from C3H mice, were maintained in vitro in Eagle's minimum essential medium containing 10% fetal bovine serum. -nitro-L-arginine methyl ester (L-NAME; DOJINDO, Kumamoto, Japan) was intraperitoneally injected into tumor-bearing mice at 30 mg/kg at 30 min before irradiation, followed by ad lib administration in drinking water at a concentration of 500 mg/L [8] .
All animal experiments were performed according to the established guidelines of the "Law for The Care and Welfare of Animals in Japan", and approved by the Animal Experiment Committee of the Graduate School of Veterinary Medicine, Hokkaido University.
In vivo ESR oxymetry
An oxygen-sensitive probe, lithium 5,9,14,18,23,27,32,36-octa-n-butoxy-2,3-naphthalocyanine (LiNc-BuO) was prepared according to a previous report [9] . In vivo ESR oxymetry was performed as described elsewhere [10] . In brief, LiNc-BuO suspension was implanted in tumors (200 μg/mouse in 20 μl PBS containing 5% dextran) and mice were left for longer than 24 h before ESR measurement. The ESR spectra of LiNc-BuO were recorded using a JES-TE200
continuous-wave L-band ESR spectrometer with a surface-coil resonator (JEOL, Tokyo, Japan). 
Immunohistochemistry
Pimonidazole (Hypoxyprobe-1 Kit; Hypoxyprobe, Inc., Burlington, MA) was intravenously administered to tumor-bearing mice at 1 h before IR to label the region of primarily existing hypoxia. EF5 (supplied by Dr. C. J. Koch [11] ) was then administered to mice at 23 h or 47 h after IR to label the region of altered hypoxia. Tumor tissues were excised at 1 h after EF5 injection, fixed with 4% buffered formaldehyde, embedded in paraffin, and sectioned at 3-μm thick. After antigen retrieval and blocking of non-specific binding, slides were probed with Images of ten fields from each sample were acquired at ×100 magnification using a fluorescence microscope (BX61; Olympus, Tokyo, Japan) equipped with a digital camera (DP71; Olympus), and the pixel number of the pimonidazole-or EF5-positive areas in each image was quantified using ImageJ software (National Institutes of Health, MD, USA). To evaluate the change in tumor hypoxia, the ratio of the pixel number of EF5-positive areas to that of the pimonidazole-positive areas was calculated.
Analysis of tissue perfusion in tumors
The status of tissue perfusion in tumors after IR was evaluated by the administration of Hoechst 33342 (H33342; DOJINDO, Kumamoto, Japan) as an exogenous perfusion marker [12] . The H33342 signals in the frozen sections were recorded and analyzed as described above. To perform quantitative analysis, the pixel number of H33342-positive areas were divided by that of the total tumor area and expressed as the perfusion area (%).
Western blotting
Western blot analyses for 3-nitrotyrosine (3-NT), iNOS, eNOS, and CD31, cyclooxygenase-2 (Cox-2), were performed according to a previous report [13] . Proteins separated by SDS-PAGE were transferred to a nitrocellulose membrane (ADVANTEC Toyo, Tokyo, Japan). Membranes were probed with antibodies against 3-NT, iNOS, eNOS, CD31 (Abcam, Cambridge, UK), and
Cox-2 (Santa Cruz Biotechnology, Santa Cruz, CA) and subsequent HRP-conjugated secondary antibodies.
RT-PCR analysis
Total RNA from the excised tumors was isolated using a SV Total RNA Isolation system performed the assays in the presence or absence of a general NOS inhibitor, L-NAME, or an iNOS selective inhibitor, 1400W (Wako Pure Chemical Industries, Osaka, Japan).
Statistical analysis
All values are expressed as means ± S.E. of three to eight independent experiments. Differences between groups were evaluated by Student's t-test (two-sided) and considered to be significant at P<0.05.
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RESULTS
Radiation-induced NO modulates tumor oxygenation status
To perform a detailed analysis of the temporal changes in tumor oxygenation status after IR, we employed in vivo ESR oxymetry, which allowed us to measure tumor pO 2 continuously. ESR oxymetry showed that IR induced a rapid increase in tumor pO 2 from 4.3 mmHg to 17.4 mmHg at 24 h. After the first reoxygenation, tumor pO 2 decreased to 7.7 mmHg at 48 h after irradiation and remained elevated up to 120 h (Fig. 1A) . Moreover, L-NAME treatment inhibited the early increase of pO 2 after IR, whereas the late plateau phase from 48 h was not affected (Fig. 1A) .
These results indicated that IR-induced NO was involved in the increase in tissue pO 2 at 12 h and 24 h after IR.
Next, to clarify the spatiotemporal changes of tumor hypoxia, we performed an immunohistochemical analysis using two hypoxia probes, pimonidazole and EF5. To this end, these two probes were separately injected into mice before and after irradiation, with the aim of labeling two different hypoxic regions; the first probe, pimonidazole, accumulates to the pre-existing hypoxic regions, and the second probe, EF5, accumulates to the newly-emerged hypoxic regions after IR. As shown in Figure 1B, we found a similar level of pimonidazole accumulation in all groups, indicating that the extent of tumor hypoxia before IR was almost equal. When EF5 was injected 1 h after pimonidazole administration, the complete colocalization of these probes in the tumors was observed ( Fig. 1B; left) . When transplanted tumors were irradiated at 1 h after pimonidazole injection, followed by EF5 injection at 24 h after IR, the EF5-positive regions were reduced compared to the pimonidazole-positive regions
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( Fig. 1B; middle) . At 48 h after IR, the EF5-positive regions reemerged and partly overlapped with the pimonidazole-positive regions ( Fig. 1B; right) . In addition, we performed positron emission tomography (PET) scanning using [ 18 F]-FMISO as a radiolabeled hypoxia marker. In tumors at 24 h after 13 Gy X-irradiation, PET images showed that the uptake of [ 18 F]-FMISO was diminished after irradiation ( Supplementary Fig. 1A) . Similarly, the autoradiographs for Fig. 1D ). These results indicated that X-irradiation induced tumor reoxygenation without affecting tumor size.
While IR induced a substantial decrease in EF5-positive areas at 24 h after IR in the absence of L-NAME (Fig. 1B) , L-NAME treatment clearly prevented it ( Fig. 1C; middle) .
Quantitative analysis showed significant decreases in the EF5/pimonidazole fraction ratio at 24
h and 48 h after IR (13.1% and 58.2% of pimonidazole-positive fractions, respectively) ( Fig.   1D ). In the presence of L-NAME, IR resulted in a gradual reduction of the EF5/pimonidazole fraction ratio up to 48 h after irradiation (78.7% at 24 h and 56.4% at 48 h) (Fig. 1D) . It was significantly different from the change in the EF5/pimonidazole fraction ratio after irradiation without L-NAME (Fig. 1D) , suggesting the involvement of IR-induced NO in the tumor reoxygenation.
Radiation-induced NO increases intratumoral circulation
Several reports have demonstrated that IR-induced NO production is associated with an increase in intratumoral blood circulation and tissue perfusion via vasodilation [4, 14] . We thus performed a H33342 perfusion assay to evaluate the blood supply to tumor tissues after IR (13 Gy). As shown in Figure 2A , the perfused areas were increased after irradiation, indicating that IR enhanced blood supply in the tumors. Quantitative analysis showed that the perfused areas in tumors at 24 and 48 h after IR (30.9% and 31.3%, respectively) were three times larger than those in the nonirradiated control (8.5%) (Fig. 2B) .
To investigate the involvement of NO in the IR-induced tissue perfusion, we tested the effect of L-NAME. Administration of L-NAME completely inhibited the increase of the perfused area by IR at 24 h, but this inhibition disappeared at 48 h (24.5%) (Fig. 2B ). To clarify whether IR stimulates NO production in tumors, we examined the protein nitration levels after IR by western blotting for 3-NT [15] . Figure 2C shows that several bands of nitrated protein (indicated by arrows) were increased in X-irradiated tumors, suggesting that IR induced NO production. We also tested the effect of L-NAME on NO production in X-irradiated tumors and found that the administration of L-NAME to tumor-bearing mice at 30 min before IR abolished the increase in 3-NT levels at 24 h after irradiation (Fig.2C) .
IR increases eNOS activity in SCCVII tumors
To determine the source of IR-induced NO, we next evaluated the mRNA and protein expression levels of the NOS isoforms (nNOS, iNOS, and eNOS). RT-PCR analysis revealed that the mRNA levels of each NOS isoform were not changed after IR (Fig.3A) . In addition, nNOS mRNA was hardly detectable in SCCVII tumors (nNOS mRNA in nonirradiated tumor; Cq = 0.009 ± 0.001, irradiated tumor; Cq = 0.011 ± 0.003). This result led us to exclude nNOS from further analysis. As shown in Figure 3B , western blot analysis showed that IR did not increase the protein expression levels of iNOS and eNOS. Furthermore, we observed no difference in the protein expression levels of CD31 and Cox-2 between control and X-irradiated tumors, suggesting that neither angiogenesis nor inflammation had occurred at 18 h after IR (Fig. 3B) . We then tested the enzymatic activities of NOS in tumor-tissue extracts with or without IR. It showed that IR increased NOS activity in tumors ( Fig. 3C; DMSO [1%] ). These results suggested that NO production in X-irradiated tumors was not due to altered NOS protein expression, but to increased enzymatic activity of either iNOS or eNOS.
To determine which NOS isoform plays a role in NO production after IR, we evaluated the effect of a general NOS inhibitor, L-NAME, and an iNOS-specific inhibitor, 1400W, on NOS activity using protein extracts from SCCVII tumors. While L-NAME treatment significantly inhibited IR-induced upregulation of NOS activity, 1400W did not (Fig. 3C ).
These results indicated that eNOS but not iNOS was responsible for NOS activation in irradiated tumors.
Radiation-induced NO increases tumor radiosensitivity
The hypoxic region in tumors is an important factor to determine the efficacy of radiation therapy. Because radiation-induced NO decreased tumor hypoxia at 12 h and 24 h after IR ( Fig.   1) , we evaluated the effect of radiation-induced NO on tumor growth after fractionated irradiation. Tumor growth delay assay showed that the fractionated irradiation at intervals of 18 h (10 Gy × 2) clearly decreased tumor growth rate (Fig. 4) . To examine the effect of L-NAME on this anti-tumor effect, tumor-bearing mice were treated with L-NAME after the first irradiation until the second irradiation. As a result, we found that L-NAME significantly diminished the anti-tumor effect caused by the fractionated irradiation (Fig. 4) .
DISCUSSION
We conducted this study to elucidate the mechanism by which IR stimulates NO production in To investigate the involvement of IR-induced NO in the changes in tissue perfusion, tissue pO 2 , and tumor hypoxia, we tested the effect of L-NAME. L-NAME treatment significantly inhibited the early increases of perfusion and pO 2 after IR ( Figs. 1 and 2 ). Crokart et al. proposed that IR-induced inflammation is involved in the increase in tumor pO 2 , based on their observation that an anti-inflammation drug diclofenac partly inhibited the reoxygenation [18] . However, as shown in Figure 3B , we did not observe an increase in an inflammation marker, Cox-2, suggesting that IR-induced inflammation did not occur in these experimental conditions.
Although IR increased protein nitration, the mRNA and protein levels of NOS isoforms did not change after IR (Figs. 2C and 3AB ). In addition, the IR-induced increase in NOS activity was inhibited by a general NOS inhibitor L-NAME, but not by an iNOS-specific inhibitor, 1400W (Fig. 3C ). We confirmed that this concentration of 1400W completely inhibited iNOS activity purified from murine macrophages (data not shown). Moreover,
RT-PCR analysis showed that nNOS was poorly expressed in SCCVII tumors (Fig 3B) . These results suggested that eNOS is responsible for IR-induced NO production. At present, it remains unclear how IR triggers eNOS activation in vascular endothelial cells. Since the phosphorylation of eNOS is known to be important in the regulation of its activity, further examination of its phosphorylation mechanism is required to understand IR-induced reoxygenation in solid tumors.
In conclusion, the present study demonstrated that IR stimulated NO production via the activation of eNOS, leading to a reduction in hypoxic regions in tumors. Importantly, L-NAME treatment attenuated the anti-tumor effect of the fractionated radiation (10 Gy x 2) in vivo. These results suggested that the first round of IR decreases hypoxic regions in tumors through eNOS upregulation, leading to an increase in tumor radiosensitivity against the second IR round. These findings may provide new insights for the development of effective radiation therapy for solid tumors. X-irradiated tumors without L-NAME. (C) Representative images of western blotting for 3-NT.
Mice were divided into three groups: control (Nonirradiated), IR only (13 Gy, 24 h), and IR + L-NAME (13 Gy with L-NAME, 24 h). after IR (white square, 0 Gy without L-NAME; black squares, 0 Gy with L-NAME; white triangle, 10 Gy × 2 without L-NAME; black triangle, 10 Gy × 2 with L-NAME). Error bars represent S.E. *P<0.05 vs. 10 Gy × 2 without L-NAME.
